|
Aug 8
|
Renal Transplant Therapeutics Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Calcineurin Inhibitors Dominate Renal Transplant Therapeutics Market
|
|
Aug 8
|
Pneumococcal Disease Pipeline Market Research 2025 | Therapeutic Assessments by Product Type, Stage, Administration Route, and Molecule Type
|
|
Aug 7
|
NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View
|
|
Aug 7
|
Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
|
|
Aug 7
|
United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
|
|
Aug 7
|
RFK Jr’s mRNA funding halt signals “shift in US public health”
|
|
Aug 7
|
SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates
|
|
Aug 6
|
RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
|
|
Aug 6
|
Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales
|
|
Aug 6
|
Novavax lifts 2025 revenue outlook after FDA milestone payment
|
|
Aug 6
|
Novavax banks on vaccine supply partnerships to boost 2025 revenue
|
|
Aug 6
|
Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights
|
|
Aug 6
|
US Health Department Ending Federal mRNA Vaccine Development
|
|
Aug 6
|
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
|
|
Aug 5
|
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
|
|
Aug 4
|
Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
|
|
Aug 4
|
Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?
|
|
Aug 4
|
Arrowhead sells China hypertriglyceridemia candidate rights to Sanofi
|
|
Aug 1
|
Health Care Roundup: Market Talk
|
|
Aug 1
|
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
|